Cargando…
Pleural cytokines MIF and MIP-3α as novel biomarkers for complicated parapneumonic effusions and empyema
Patients with complicated parapneumonic effusion (CPPE)/empyema have high morbidity and mortality, particularly when adequate management is delayed. We aimed to investigate novel dysregulated cytokines that can be used as biomarkers for infectious pleural effusions, especially for CPPE/empyema. Expr...
Autores principales: | Yang, Chia-Yu, Kuo, Yu-Hsuan, Chen, Min, Wang, Chih-Liang, Shih, Li-Jane, Liu, Yu-Ching, Hsueh, Pei-Chun, Lai, Yi-Hsuan, Chu, Chi-Ming, Wu, Chih-Ching, Wu, Kuo-An |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815762/ https://www.ncbi.nlm.nih.gov/pubmed/33469074 http://dx.doi.org/10.1038/s41598-021-81053-6 |
Ejemplares similares
-
Combined serum biomarkers in the noninvasive diagnosis of complicated parapneumonic effusions and empyema
por: Wu, Kuo-An, et al.
Publicado: (2019) -
Treatment of complicated parapneumonic pleural effusion and pleural parapneumonic empyema
por: Suárez, Pedro Rodríguez, et al.
Publicado: (2012) -
Proteome profiling reveals novel biomarkers to identify complicated parapneumonic effusions
por: Wu, Kuo-An, et al.
Publicado: (2017) -
Serum and Pleural Fluid Procalcitonin in Predicting Bacterial Infection in Patients with Parapneumonic Effusion
por: Ko, Yang-Ching, et al.
Publicado: (2009) -
Predictive Value of Pleural Cytology in the Diagnosis of Complicated Parapneumonic Effusions and Empyema Thoracis
por: Ferguson, John, et al.
Publicado: (2020)